Condition
Voice Disorder
Total Trials
7
Recruiting
0
Active
0
Completed
3
Success Rate
60.0%-27% vs avg
Key Insights
Highlights
Success Rate
60% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
28.6%
2 terminated out of 7 trials
Success Rate
60.0%
-26.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results60% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed3
Not Yet Recruiting2
Terminated2
Trial Success Rate
60.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT07371351Not ApplicableNot Yet Recruiting
"Effects of EMST and Triflo on Voice Parameters and Vocal Fatigue"
NCT06934265Not ApplicableNot Yet Recruiting
PhoRTE® Therapy Efficacy: In-Person Versus Telehealth
NCT03696576Not ApplicableTerminatedPrimary
Expiratory Muscle Strength Training and Phonation Resistance Training Exercises For Elderly Patients With Vocal Fold Atrophy
NCT00001308Terminated
Central Mechanisms in Speech Motor Control Studied With H215O PET
NCT00001552Completed
Characteristics of Idiopathic Familial Voice Disorders
NCT00001922Completed
Sensory Function in Idiopathic Voice Disorders
NCT01199172Not ApplicableCompletedPrimary
Prevention and Treatment of Voice Problems in Teachers
Showing all 7 trials